Biogelx

About:

Biogelx is a biomaterials company which designs and supplies peptide hydrogels for cell culture.

Website: http://biogelx.com/

Twitter/X: biogelx

Top Investors: Scottish Enterprise, Gabriel Investments, Pitch@Palace

Description:

Biogelx is a biomaterials company which designs and supplies peptide hydrogels for cell culture, precisely tuned to the requirements of the cell. These products have applications in fundamental cell research, toxicology/drug development and may ultimately be translated to cell therapy/regenerative medicine. The chemical and physical properties of the hydrogels match the characteristics experienced by cells within tissues, thus enabling the study and manipulation of cells in a realistic 3D environment which is simple, fully defined and tuneable. The Company's patented hydrogel products are currently selling in the US, Europe and Asia. The product's unique cell-matching capabilities clearly provide academic users, medical researchers and pharmaceutical companies with a serious alternative to competing 3D cell culture products.

Total Funding Amount:

790000 GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newhouse, North Lanarkshire, United Kingdom

Founded Date:

2012-01-01

Contact Email:

info(AT)biogelx.com

Founders:

David Lightbody, Rein Ulijn

Number of Employees:

1-10

Last Funding Date:

2017-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai